产品名称
抗-CD44v6抗体（外显子v6）, Chemicon®, from rabbit
biological source
rabbit
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
polyclonal
species reactivity
human, canine, mouse, bovine, pig, rabbit
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... CD44(960)
Application
ELISA：1：1000-1：2000
流式细胞术：1：500-1：1，000.
免疫荧光： 1：100-1：200
石蜡包埋组织的免疫组织化学染色：1：150-1：250
免疫沉淀：1：100-1：200
蛋白质印迹 1：5000-1：10,000
RIA: 1:5,000
最佳工作稀释度必须由最终用户进行确定。
流式细胞术：1：500-1：1，000.
免疫荧光： 1：100-1：200
石蜡包埋组织的免疫组织化学染色：1：150-1：250
免疫沉淀：1：100-1：200
蛋白质印迹 1：5000-1：10,000
RIA: 1:5,000
最佳工作稀释度必须由最终用户进行确定。
抗-CD44v6抗体（外显子v6）是针对CD44v6的抗体，用于ELISA、FC、IP、WB、IC、IH（P）。
研究子类别
粘附（CAMs）
粘附（CAMs）
研究类别
细胞结构
细胞结构
Biochem/physiol Actions
CD44v6（大约200/-250 kDa）
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Immunogen
人 CD44v6的合成肽
表位：外显子v6
Other Notes
替代：04-1123
浓度：请参考批次特异性浓缩物的检验报告。
Physical form
形式：纯化
纯化 IgG。 溶于含150 mM NaCl和0.01%叠氮化钠的10 mM磷酸盐缓冲液（pH 7.5）中的液体。
Preparation Note
自接收之日起，以未稀释的等分试样在2-8°C下保存长达12个月。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Sureerat Padthaisong et al.
Journal of translational medicine, 18(1), 64-64 (2020-02-11)
Cancer recurrence is the important problem of cholangiocarcinoma (CCA) patients, lead to a very high mortality rate. Therefore, the identification of candidate markers to predict CCA recurrence is needed in order to effectively manage the disease. This study aims to
Hury Viridiana Hernández-Galdámez et al.
Food & function, 15(8), 4586-4602 (2024-04-09)
Hepatocellular carcinoma (HCC) is a tumor with minimal chance of cure due to underlying liver diseases, late diagnosis, and inefficient treatments. Thus, HCC treatment warrants the development of additional strategies. Lactoferrin (Lf) is a mammalian multifunctional iron-binding glycoprotein of the
Yulian Wang et al.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 8(13), 2004929-2004929 (2021-07-15)
The blood-brain barrier (BBB) is the most restrictive and complicated barrier that keeps most biomolecules and drugs from the brain. An efficient brain delivery strategy is urgently needed for the treatment of brain diseases. Based on the studies of brain-targeting
X Yuan et al.
Oncogenesis, 5(11), e268-e268 (2016-11-08)
The stem cell factor SALL4 (Sal-like protein 4) plays important roles in the development and progression of cancer. SALL4 is critically involved in tumour growth, metastasis and therapy resistance. However, the underlying mechanisms responsible for the oncogenic roles of SALL4
Ayse Sahaboglu et al.
Scientific reports, 6, 39537-39537 (2016-12-23)
The enzyme poly-ADP-ribose-polymerase (PARP) mediates DNA-repair and rearrangements of the nuclear chromatin. Generally, PARP activity is thought to promote cell survival and in recent years a number of PARP inhibitors have been clinically developed for cancer treatment. Paradoxically, PARP activity
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持